{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T09:43:47Z","timestamp":1792230227271,"version":"4.4.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,5]]},"DOI":"10.7759\/cureus.48337","type":"journal-article","created":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T07:34:03Z","timestamp":1699256043000},"source":"Crossref","is-referenced-by-count":5,"title":["Cytomegalovirus Retinitis in a Patient Taking Upadacitinib: A Case Report"],"prefix":"10.7759","author":[{"given":"Hiromasa","family":"Hirai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Akai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahoko","family":"Ogata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuo","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.7573\/dic.212595","article-title":"Upadacitinib and filgotinib: the role of JAK1 selective inhibition in the treatment of rheumatoid arthritis","volume":"8","author":"Biggioggero M","year":"2019","unstructured":"Biggioggero M, Becciolini A, Crotti C, Agape E, Favalli EG. Upadacitinib and filgotinib: the role of JAK1 selective inhibition in the treatment of rheumatoid arthritis. Drugs Context. 2019, 8:212595. 10.7573\/dic.212595","journal-title":"Drugs Context"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2008250","article-title":"Trial of upadacitinib or abatacept in rheumatoid arthritis","volume":"383","author":"Rubbert-Roth A","year":"2020","unstructured":"Rubbert-Roth A, Enejosa J, Pangan AL, et al.. Trial of upadacitinib or abatacept in rheumatoid arthritis. N Engl J Med. 2020, 383:1511-21. 10.1056\/NEJMoa2008250","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-021-00582-z","article-title":"Pathogenesis of human cytomegalovirus in the immunocompromised host","volume":"19","author":"Griffiths P","year":"2021","unstructured":"Griffiths P, Reeves M. Pathogenesis of human cytomegalovirus in the immunocompromised host. Nat Rev Microbiol. 2021, 19:759-73. 10.1038\/s41579-021-00582-z","journal-title":"Nat Rev Microbiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms8010055","article-title":"Cytomegalovirus retinitis in HIV and non-HIV individuals","volume":"8","author":"Munro M","year":"2019","unstructured":"Munro M, Yadavalli T, Fonteh C, Arfeen S, Lobo-Chan AM. Cytomegalovirus retinitis in HIV and non-HIV individuals. Microorganisms. 2019, 8:55. 10.3390\/microorganisms8010055","journal-title":"Microorganisms"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop","volume":"140","author":"Jabs DA","year":"2005","unstructured":"Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005, 140:509-16. 10.1016\/j.ajo.2005.03.057","journal-title":"Am J Ophthalmol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s41927-018-0031-x","article-title":"In vitro and in vivo characterization of the JAK1 selectivity of upadacitinib (ABT-494)","volume":"2","author":"Parmentier JM","year":"2018","unstructured":"Parmentier JM, Voss J, Graff C, et al.. In vitro and in vivo characterization of the JAK1 selectivity of upadacitinib (ABT-494). BMC Rheumatol. 2018, 2:23. 10.1186\/s41927-018-0031-x","journal-title":"BMC Rheumatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-016-0190-5","article-title":"Recent progress in JAK inhibitors for the treatment of rheumatoid arthritis","volume":"30","author":"Nakayamada S","year":"2016","unstructured":"Nakayamada S, Kubo S, Iwata S, Tanaka Y. Recent progress in JAK inhibitors for the treatment of rheumatoid arthritis. BioDrugs. 2016, 30:407-19. 10.1007\/s40259-016-0190-5","journal-title":"BioDrugs"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-021-00410-z","article-title":"Safety profile of upadacitinib up to 3 years in psoriatic arthritis: an integrated analysis of two pivotal phase 3 trials","volume":"9","author":"Burmester GR","year":"2022","unstructured":"Burmester GR, Winthrop K, Blanco R, et al.. Safety profile of upadacitinib up to 3 years in psoriatic arthritis: an integrated analysis of two pivotal phase 3 trials. Rheumatol Ther. 2022, 9:521-39. 10.1007\/s40744-021-00410-z","journal-title":"Rheumatol Ther"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2147\/CEG.S367086","article-title":"Clinical evaluation of upadacitinib in the treatment of adults with moderately to severely active ulcerative colitis (UC): patient selection and reported outcomes","volume":"16","author":"Irani M","year":"2023","unstructured":"Irani M, Fan C, Glassner K, Abraham BP. Clinical evaluation of upadacitinib in the treatment of adults with moderately to severely active ulcerative colitis (UC): patient selection and reported outcomes. Clin Exp Gastroenterol. 2023, 16:21-8. 10.2147\/CEG.S367086","journal-title":"Clin Exp Gastroenterol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2212728","article-title":"Upadacitinib induction and maintenance therapy for Crohn's disease","volume":"388","author":"Loftus EV Jr","year":"2023","unstructured":"Loftus EV Jr, Pan\u00e9s J, Lacerda AP, et al.. Upadacitinib induction and maintenance therapy for Crohn's disease. N Engl J Med. 2023, 388:1966-80. 10.1056\/NEJMoa2212728","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2017.03.002","article-title":"Cytomegalovirus retinitis followed by immune recovery uveitis in an elderly patient with rheumatoid arthritis undergoing administration of methotrexate and tofacitinib combination therapy","volume":"23","author":"Yanagisawa K","year":"2017","unstructured":"Yanagisawa K, Ogawa Y, Hosogai M, et al.. Cytomegalovirus retinitis followed by immune recovery uveitis in an elderly patient with rheumatoid arthritis undergoing administration of methotrexate and tofacitinib combination therapy. J Infect Chemother. 2017, 23:572-5. 10.1016\/j.jiac.2017.03.002","journal-title":"J Infect Chemother"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez681","article-title":"Tofacitinib-associated cytomegalovirus retinitis","volume":"59","author":"Cugley DR","year":"2020","unstructured":"Cugley DR, Darby J, Lim LL. Tofacitinib-associated cytomegalovirus retinitis. Rheumatology (Oxford). 2020, 59:e35-7. 10.1093\/rheumatology\/kez681","journal-title":"Rheumatology (Oxford)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0238257","article-title":"Prognostic factors of cytomegalovirus retinitis after hematopoietic stem cell transplantation","volume":"15","author":"Kim JY","year":"2020","unstructured":"Kim JY, Hong SY, Park WK, et al.. Prognostic factors of cytomegalovirus retinitis after hematopoietic stem cell transplantation. PLoS One. 2020, 15:e0238257. 10.1371\/journal.pone.0238257","journal-title":"PLoS One"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0221793","article-title":"Cytomegalovirus antigenemia in patients with autoimmune and non-autoimmune diseases in Beijing: a 10-year single hospital experience","volume":"14","author":"Cui J","year":"2019","unstructured":"Cui J, Yan W, Xie H, Xu S, Wang Q, Zhang W, Ni A. Cytomegalovirus antigenemia in patients with autoimmune and non-autoimmune diseases in Beijing: a 10-year single hospital experience. PLoS One. 2019, 14:e0221793. 10.1371\/journal.pone.0221793","journal-title":"PLoS One"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/ICB.0b013e31804d1e3f","article-title":"Cytomegalovirus retinitis after intravitreous triamcinolone treatment of a vitrectomized eye in an immunocompetent patient","volume":"1","author":"Furukawa M","year":"2007","unstructured":"Furukawa M, Kumagai K, Ogino N, Okinami S, Uemura A, Larson E. Cytomegalovirus retinitis after intravitreous triamcinolone treatment of a vitrectomized eye in an immunocompetent patient. Retin Cases Brief Rep. 2007, 1:205-7. 10.1097\/ICB.0b013e31804d1e3f","journal-title":"Retin Cases Brief Rep"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajoc.2021.101055","article-title":"Cytomegalovirus retinitis following dexamethasone intravitreal implant","volume":"22","author":"Chaudhry SG","year":"2021","unstructured":"Chaudhry SG, Fung AT. Cytomegalovirus retinitis following dexamethasone intravitreal implant. Am J Ophthalmol Case Rep. 2021, 22:101055. 10.1016\/j.ajoc.2021.101055","journal-title":"Am J Ophthalmol Case Rep"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-021-06311-4","article-title":"Frosted branch angiitis due to cytomegalovirus-associated unmasking immune reconstitution inflammatory syndrome: a case report and literature review","volume":"21","author":"Tang S","year":"2021","unstructured":"Tang S, Zhao N, Wang LY, Wen Y. Frosted branch angiitis due to cytomegalovirus-associated unmasking immune reconstitution inflammatory syndrome: a case report and literature review. BMC Infect Dis. 2021, 21:613. 10.1186\/s12879-021-06311-4","journal-title":"BMC Infect Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/198838-cytomegalovirus-retinitis-in-a-patient-taking-upadacitinib-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:08:53Z","timestamp":1707509333000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/198838-cytomegalovirus-retinitis-in-a-patient-taking-upadacitinib-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,5]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.48337","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11,5]]}}}